Literature DB >> 9049323

The role of repetitive DNA sequences in the size variation of Epstein-Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR analysis.

K Falk1, J W Gratama, M Rowe, J Z Zou, F Khanim, L S Young, M A Oosterveer, I Ernberg.   

Abstract

The six Epstein-Barr virus (EBV) nuclear antigen proteins (EBNA-1-6) show characteristic size variations between different virus isolates; this is a feature that has been used to identify the source of virus isolates in epidemiological studies (Ebnotyping). We have now studied the correlation between restriction fragment length polymorphisms (RFLPs) within exons coding for the EBNAs and the molecular masses of the respective proteins. The B95-8 EBV strain was used as the prototype virus. The variation in apparent molecular mass of EBNA-1, -3 and -6 correlated positively with the size of RFLP coding for repeat sequences in these polypeptides. For EBNA-2, no correlation between apparent molecular mass and length of the repetitive sequences was found. The EBNA-4 protein showed virtually no variation in apparent molecular mass and RFLP size across the repeat sequence. Based on the strong correlation between apparent molecular mass and RFLP size for EBNA-6, we developed an EBNA-6 PCR assay that discriminated between different isolates of EBV. This assay offers the advantage of EBV characterization using uncultured material (e.g. throat washings, blood or biopsies), thus avoiding the selection against poorly transforming strains that occurs during establishment of lymphoblastoid cell lines required for Ebnotyping at the protein level.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9049323     DOI: 10.1099/0022-1317-76-4-779

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

Review 1.  Methods for subtyping and molecular comparison of human viral genomes.

Authors:  M Arens
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

2.  Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.

Authors:  N W Blake; A Moghaddam; P Rao; A Kaur; R Glickman; Y G Cho; A Marchini; T Haigh; R P Johnson; A B Rickinson; F Wang
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  High avidity binding to DNA protects ubiquitylated substrates from proteasomal degradation.

Authors:  Giuseppe Coppotelli; Nouman Mughal; Diego Marescotti; Maria G Masucci
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.157

4.  Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

Authors:  J Levitskaya; A Sharipo; A Leonchiks; A Ciechanover; M G Masucci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

5.  B-lymphoblastoid cell lines from cancer patients.

Authors:  W K Lee; S M Kim; Y S Sim; S G Cho; S H Park; C W Kim; J G Park
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-02       Impact factor: 2.416

6.  Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals.

Authors:  Q Y Yao; R J Tierney; D Croom-Carter; G M Cooper; C J Ellis; M Rowe; A B Rickinson
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

7.  Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals.

Authors:  Q Y Yao; R J Tierney; D Croom-Carter; D Dukers; G M Cooper; C J Ellis; M Rowe; A B Rickinson
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

8.  Slippery substrates impair function of a bacterial protease ATPase by unbalancing translocation versus exit.

Authors:  Priscilla Hiu-Mei Too; Jenny Erales; Joana Danica Simen; Antonija Marjanovic; Philip Coffino
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

9.  Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas.

Authors:  G Habeshaw; Q Y Yao; A I Bell; D Morton; A B Rickinson
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Multiple Epstein-Barr virus infections in healthy individuals.

Authors:  Dennis M Walling; Abigail L Brown; Wiguins Etienne; Wendy A Keitel; Paul D Ling
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.